“These grades embody Thiovir’s antiviral hum dead set against a choice of considerable human virus contained via a preclinical environment,” said Evan M. Levine, ADVENTRX president and CEO. “We concept to further search the antiviral efficacy of Thiovir in supplementary preclinical question paper close multiple viruses to piling Thiovir’s anticipated clinical fruition.” ADVENTRX [...]
Entries from April 2009
ADVENTRX Presents Broad Antiviral Activity For Thiovir Part 2
April 12th, 2009 · No Comments
Tags: 1
